WHO Drug Information - Volume 35, No. 4
28 January 2022
| Publication

Overview
The fourth issue of Volume 35, includes
Regulatory News:
- Extraordinary (Virtual) Conference of Drug Regulatory Authorities (ICDRA) - Recommendations
Pharmaceutical News:
- International Nonproprietary Names: Translating the Science of Nomenclature into a Global Language for Education and Practice
- Prescribing with International Nonproprietary Names - Facilitating Communication and Improving Access to Medical Substances by Increasing the Use of Non-originator Pharmaceutical Products
Consultation Documents:
- Sodium Starch Glycolate (natrii amyla glycolas)
- Hydroxypropylcellulose, low-substituted (hydroxypropylcellulosum substitutum humile)
- Sodium laurilsulfate (natrii laurilsulfas)
- Isoniazid (isoniazidum)
ATC/DDD Classification:
- Temporary
- Final
International Nonproprietary Names List:
Issue 4 concludes with List No. 126 of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances:
- Proposed INN List 126: from page 929 to 1127 (deadline for objecting and commenting is 27 May 2022)
- Proposed INN List 126 - COVID-19 (Special edition): from page 1129 to 1146 (deadline for objecting and commenting is 27 May 2022)
- Proposed INN List 126 - COVID-19 (Special edition) ADDENDUM: from page 1147 to 1148 (deadline for objecting and commenting is 11 February 2022)
WHO Team
Access to Medicines and Health Products (MHP),
INN and Classification of Medical Products (INN),
Prequalification (PQT),
Regulation and Prequalification (RPQ),
Regulation and safety (REG)
Editors
World Health Organization
Number of pages
324
Reference numbers
ISBN: 978 92 4 004216 2